Rituximab in non-haematological disorders of adults and its mode of action.
about
Rituximab use in adult primary glomerulopathy: where is the evidence?Prospective data collection of off-label use of rituximab in Australian public hospitals.Subcutaneous immunoglobulin in lymphoproliferative disorders and rituximab-related secondary hypogammaglobulinemia: a single-center experience in 61 patients.Autoimmunity as a predisposition for infectious diseasesTreatment of Sarcoidosis.Adult Living Donor Liver Transplantation Across ABO-Incompatibility.Refractory myasthenia gravis - clinical profile, comorbidities and response to rituximab.Focal rituximab-induced edematous reaction at primary cutaneous follicle center lymphoma lesions: case report and literature review.Response of patients with refractory myasthenia gravis to rituximab: a retrospective study.Current and emerging treatment options for interstitial lung disease in patients with rheumatic disease.Stability of stock and diluted rituximab.Pneumocystis pneumonia versus rituximab-induced interstitial lung disease in lymphoma patients receiving rituximab-containing chemotherapy.Primary renal lymphoma: long-term results of two patients treated with a chemotherapy + rituximab protocolRituximab in pemphigus.Rituximab Induced Interstitial Lung Disease in Patients with Non-Hodgkin’s Lymphoma: A Clinical Study of Six Cases and Review of the Literature
P2860
Q28075564-31BAF8E7-A821-484A-9EA5-CFB738CE009BQ30640279-03A95864-E759-454E-B488-C53B6D93FAF8Q33695997-D72516B0-A4FA-4804-A454-2F2F548AA824Q33747588-1022A5DC-DCD8-4C5E-B039-692A8C045B3BQ34477003-F3C83B8C-950D-4BE4-9C60-72C09D5BB073Q36206934-1FD26BA3-F42B-4E92-ADF0-1507CC47D84DQ37344993-F8ADBEB1-4AB9-48F2-B22D-E29373CFC2D0Q37943941-9C65411B-3E43-43DD-A7FA-6D9E635A9F24Q38633453-312C667C-D7A3-4D24-8E28-621A657E2268Q38692232-E520E3DB-451B-4C1B-B1D7-F3F38A2322C1Q38759335-5303A1C5-0A7D-447C-9C9F-212A21F00503Q40124892-37781EF0-923B-4746-BFBA-CD8E2939146DQ42175821-21456EDB-7FC2-451B-97FA-964615905516Q50075561-2B6D62DC-9812-49EF-A2C1-59A328EDE39DQ59048666-8C6023D2-56B7-4B2F-8109-F9F6DE9FF413
P2860
Rituximab in non-haematological disorders of adults and its mode of action.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rituximab in non-haematological disorders of adults and its mode of action.
@en
Rituximab in non-haematological disorders of adults and its mode of action.
@nl
type
label
Rituximab in non-haematological disorders of adults and its mode of action.
@en
Rituximab in non-haematological disorders of adults and its mode of action.
@nl
prefLabel
Rituximab in non-haematological disorders of adults and its mode of action.
@en
Rituximab in non-haematological disorders of adults and its mode of action.
@nl
P1476
Rituximab in non-haematological disorders of adults and its mode of action.
@en
P2093
Maria Leandro
Vickie McDonald
P304
P356
10.1111/J.1365-2141.2009.07718.X
P407
P577
2009-05-19T00:00:00Z